Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 847       
REVIEW ARTICLE
Year : 2014  |  Volume : 139  |  Issue : 2  |  Page : 205-215

Antimalarial drug policy in India: Past, present & future


1 National Institute of Malaria Research (ICMR), New Delhi, India
2 National Vector Borne Disease Control Programme, Delhi, India

Correspondence Address:
Anupkumar R Anvikar
Scientist D, National Institute of Malaria Research (ICMR) Sector 8, Dwarka, New Delhi 110 077
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 24718394

Rights and PermissionsRights and Permissions

The use of antimalarial drugs in India has evolved since the introduction of quinine in the 17 th century. Since the formal establishment of a malaria control programme in 1953, shortly after independence, treatments provided by the public sector ranged from chloroquine, the mainstay drug for many decades, to the newer, recently introduced artemisinin based combination therapy. The complexity of considerations in antimalarial treatment led to the formulation of a National Antimalarial Drug Policy to guide procurement as well as communicate best practices to both public and private healthcare providers. Challenges addressed in the policy include the use of presumptive treatment, the introduction of alternate treatments for drug-resistant malaria, the duration of primaquine therapy to prevent relapses of vivax malaria, the treatment of malaria in pregnancy, and the choice of drugs for chemoprophylaxis. While data on antimalarial drug resistance and both public and private sector treatment practices have been recently reviewed, the policy process of setting national standards has not. In this perspective on antimalarial drug policy, this review highlights its relevant history, analyzes the current policy, and examines future directions.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1840    
    Printed13    
    Emailed0    
    PDF Downloaded582    
    Comments [Add]    

Recommend this journal